


PDC*line Pharma announces the administration of a first patient with its therapeutic cancer vaccine candidate (PDC*lung01) targeting non-small cell lung cancer

Advanced BioDesign raises additional €9 million from Xerys Funds

Oncodesign and Servier reach a key first milestone in their strategic partnership

Domain Therapeutics is granted European and US patent for biosensors assessing GPCR trafficking

Yposkesi’s clinical batches of the G1XCGD lentiviral vector used in rare immune system disease study

Cynbiose receives €1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases

Nuvisan Pharma Services acquires Inamed GmbH

PDC*line Pharma raises €20 million in Series B financing round
